New option for control of severe asthma, lung microbiome and transplant and more

Highlights from the American Thoracic Society 2022 Conference from Michigan Medicine researchers.

5:00 AM

Author | Kelly Malcom

lungs drawing yellow blue lab note
Michigan Medicine

Research from the Division of Pulmonary and Critical Care Medicine was featured prominently at the recent conference of the American Thoracic Society, the leading medical society focused on global respiratory health. Here are a few highlights:

New treatment for severe asthma

A greater proportion of patients with severe, uncontrolled asthma had more significant clinical responses to a drug called Tezepelumab, a human monoclonal antibody therapy, than placebo, according to research published at the ATS 2022 international conference last month. The study showed that nearly half of those enrolled showed fewer exacerbations ("asthma attack"), control of their asthma and improved lung function.

"Across each measure, tezepelumab recipients were more likely to have a response; the greatest difference observed was for exacerbation reduction. In addition, 48 percent of patients receiving tezepelumab had a complete response and achieved significant and clinically relevant improvements in all four response measures," said presenting author Njira Lugogo, M.D., associate professor of internal medicine and director of the Asthma Program in the Division of Pulmonary and Critical Care Medicine.

Use of digital inhalers

There is increasing evidence that over reliance on short acting beta agonists, also referred to as SABA, is associated with increased risks of asthma exacerbations and mortality. And while clinicians are encouraged to minimize use of SABA, there are no clear guidelines on safe SABA thresholds and ways to identify SABA over-reliance.

A survey of clinical experts developed a consensus that the use of more than 3 canisters of SABA in a 12-month period could be considered a threshold before warranting clinical intervention. In a study, Lugogo and her team applied this threshold to a dataset obtained from a 12-week prospective open label trial in patients with uncontrolled asthma that were using an albuterol digital inhaler.

They identified the prevalence of SABA inhaler use above the safe threshold and calculated the positive and negative thresholds based on the presence of exacerbations in those that did and did not exceed 138 inhalations in the 12-week study period. The number needed to identify one patient that is at risk for an exacerbation was 5 patients. "Digital inhalers offer new ways to identify at risk patients and this novel technology could advance our ability to accurately risk stratify patients with asthma," Lugogo said.

Lung microbiome and transplant rejection

In another study presented at the meeting, Michael Combs, M.D., a clinical lecturer with the Division of Pulmonary and Critical Care Medicine and his team found that once lung transplant patients develop rejection, their lung microbiome predicts their mortality. In addition, they found that whether these patients do or do not benefit clinically from an antibiotic called azithromycin, a common therapy for transplant rejection, depends on their lung microbiota. The study suggests that the lung microbiome may be an overlooked treatment target for lung transplant rejection and other lung diseases.


More Articles About: Lab Notes Basic Science and Laboratory Research Asthma Lung Function Wellness and Prevention All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Close up image of red blood cells moving through veins
Health Lab
Discovery reveals how this common stinky gas is processed to promote blood vessel growth
A new collaborative study, examined the interaction between three naturally occurring gases — nitric oxide (NO), oxygen, and H2S — during generation of new blood vessels, called angiogenesis.
Photo of two silhouettes in a hallway
Health Lab
Most new doctors face some form of sexual harassment, even after #MeToo
Sexual harassment of all kinds is a common experience among first-year medical residents, also known as interns, especially those in surgical specialties, but it may be declining.
Speculum illustration including a gloved hand holding a swab in front of microscopic cells
Health Lab
U.S. could cut cervical cancer cases, deaths by up to 20% if more patients followed up after screening, study suggests
Many women don’t get cervical cancer screening such as Pap tests, or don’t go for follow up diagnostic tests; a new study shows what could happen if all of them did.
Researcher in white coat focuses gaze on microbes pictured in a twisting tube illustrating the gut
Health Lab
Fiber, genes and the gut microbiome: Study reveals possible triggers for inflammatory bowel disease
A new U-M study finds a complex interplay between diet, genes, and the gut microbiota that could explain why IBD develops.
gun with lock on it with key there gun is in black and background yellow and lock is white
Health Lab
Michigan’s new firearm injury prevention laws: What everyone should know
Michigan has a set of new laws related to firearms, all designed to reduce the risk of injury and death across the state.
Enlargement of microscopic HIV virus cells
Health Lab
Researchers open new leads in anti-HIV drug development, using compound found in nature
Researchers open new leads in anti-HIV drug development, using a compound found in nature